Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Discover yearly leaders among index funds and understand how performance shifts across periods, helping you choose resilient options.
27,236 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A bold 17-inch Wimbledon hat by a global star sparked more than fashion chatter — it raised real questions about cost...
Walmart reports a stronger holiday quarter as wealthier shoppers joined the rush, lifting overall sales and online gr...
Traders are turning toward three mid-cap miners as the tape says these growth stocks could ride higher metal prices a...
Pattern PTRN just released its Q1 2026 earnings, revealing growth drivers and fresh guidance. This analysis breaks do...
Stocks edge higher as Nvidia earnings loom, lifting the S&P 500 and Nasdaq. This stock market live 2026 update tracks...
Micron Technology has surged 93% in the last month on AI data center demand. Investors weigh whether to lock in gains...
Iran faces a sharp economic decline after renewed conflict, with staple prices surging and millions at risk of povert...
ServiceNow and IBM unveiled a broader AI-driven collaboration aimed at modernizing aging enterprise apps, with soluti...
Microsoft Copilot AI signals a bold XRP rally by year-end 2026, driven by real-world catalysts and on-chain activity....
AXT Inc. is poised for a pivotal earnings night after a dramatic rally. Look for updates on demand for indium phosphi...
SanDisk shares jumped about 6% on Friday as a persistent NAND shortage supports higher prices and prolonged demand fr...